Springer Nature
Browse
12935_2022_2464_MOESM1_ESM.docx (120.56 kB)

Additional file 1 of Addition of chemoradiotherapy to palliative chemotherapy in de novo metastatic nasopharyngeal carcinoma: a real-world study

Download (120.56 kB)
journal contribution
posted on 2022-01-25, 05:14 authored by Shuo-Han Zheng, Yu-Tong Wang, Song-Ran Liu, Zi-Lu Huang, Guan-Nan Wang, Jin-Tao Lin, Shi-Rong Ding, Chen Chen, Yun-Fei Xia
Additional file 1: Description of the radiotherapy. Figure S1. Patient selection diagram. Figure S2. Overall Survival (OS) for patients treated with chemoradiotherapy (CRT) or palliative chemotherapy (PCT) in de novo metastatic nasopharyngeal carcinoma. Table S1. Details of common chemotherapy regimens. Table S2. Summary of studies related to locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma. Table S3. Adverse effects. References.

Funding

key technology research and development program of shandong innovative research group project of the national natural science foundation of china natural science foundation of guangdong province

History

Usage metrics

    Cancer Cell International

    Categories

    Keywords

    Nasopharyngeal carcinomaMetastasisChemotherapyRadiotherapy

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC